Synthroid Cost in Oregon 2026: Levothyroxine Prices, Insurance, and Savings Options

At a glance
- AbbVie Synthroid list price / ~$50/month in Oregon (2026)
- Generic levothyroxine cash price / ~$15/month at Oregon retail pharmacies
- Oregon Health Plan (Medicaid) / Covers levothyroxine with prior authorization
- Compounded levothyroxine / Legal via licensed 503A pharmacies in Oregon
- Telehealth prescribing / Permitted in Oregon for new and existing patients
- Dosing / Once daily, oral tablet, taken on empty stomach 30 to 60 minutes before food
- AbbVie myAbbVie Assist / Free branded Synthroid for eligible uninsured patients
- Bioequivalence / FDA requires AUC and Cmax within 80 to 125% of reference product
What Does Synthroid Actually Cost in Oregon Right Now?
Branded Synthroid's 2026 list price runs approximately $50 per month in Oregon, but very few patients pay that figure. Generic levothyroxine at Oregon retail chains averages about $15 per month cash, and patients enrolled in Oregon Health Plan or employer-sponsored insurance typically pay even less. The gap between list price and out-of-pocket cost is wider for thyroid drugs than for almost any other chronic-care medication class, which makes understanding each pricing layer essential before you fill a prescription.
AbbVie holds the Synthroid new drug application and sets the branded list price independently of pharmacy markup. The FDA-approved Synthroid prescribing information confirms the drug is indicated for hypothyroidism and TSH suppression in thyroid cancer. Because levothyroxine is a narrow therapeutic index (NTI) drug, the FDA requires that all generic versions demonstrate bioequivalence with an AUC and Cmax ratio within 80 to 125% of the reference listed drug, a tighter effective window given NTI designation [1].
Oregon's 39 counties are served by a mix of national chain pharmacies (Walgreens, Rite Aid in receivership, Costco, Fred Meyer/Kroger), regional chains, and independent community pharmacies. Cash prices vary by as much as 60% across ZIP codes. Costco Pharmacy and Walmart Pharmacy consistently post the lowest cash prices in audited GoodRx data, often landing generic levothyroxine at $10, $13 per 30-day supply for common doses such as 50 mcg and 100 mcg.
The American Thyroid Association 2014 guidelines (Jonklaas et al., Thyroid, PMID 25266247) state: "Levothyroxine sodium is the recommended thyroid hormone preparation for the treatment of hypothyroidism." That single-drug recommendation means cost optimization focuses on form (branded vs. generic vs. compounded) and coverage pathway rather than therapeutic alternatives [2].
Patients on a stable dose for more than 6 months can request a 90-day supply, which typically reduces per-tablet cost by an additional 10 to 15% at most Oregon pharmacies. A 90-day fill of generic levothyroxine 100 mcg at Fred Meyer Pharmacy in Portland ran $36, $38 in early 2025, equivalent to roughly $12, $13 per month.
Does Oregon Medicaid Cover Levothyroxine?
Oregon Health Plan (OHP), the state's Medicaid program administered by the Oregon Health Authority, covers levothyroxine on its Preferred Drug List with prior authorization for both branded Synthroid and generic formulations. Prior authorization is generally approved when a prescriber documents a clinical diagnosis of hypothyroidism confirmed by thyroid-stimulating hormone (TSH) testing, a standard that nearly every legitimate thyroid patient meets within one office visit.
The Oregon Health Authority Pharmacy Program updates its PDL quarterly. As of the 2025 Q4 update, levothyroxine (generic) sits in the preferred tier, meaning OHP members with a PA approval pay $0, $3 copay per fill depending on their coordinated care organization (CCO). Branded Synthroid sits in a non-preferred tier, so prescribers who want the branded product covered must document a specific clinical reason, typically a documented intolerance to generic excipients or a historical stability concern on generic products.
Oregon Medicaid enrollees should ask their CCO's pharmacy benefit coordinator whether a 90-day supply is allowed at one time. The Oregon Integrated and Coordinated Care model, formalized under OAR 410-121, encourages 90-day maintenance medication supplies to reduce care gaps, which can apply directly to levothyroxine.
The National Alliance of State Pharmacy Associations (NASPA) 2024 State Medicaid Pharmacy Report found that states using preferred drug lists with narrow NTI drug carve-outs showed lower generic substitution rates for thyroid drugs, a pattern consistent with OHP's approach of allowing PA for branded Synthroid when clinically justified [3].
How Does Private Insurance Cover Synthroid in Oregon?
Most private insurance plans offered through Cover Oregon (now OHA Marketplace) and employer group plans place generic levothyroxine on Tier 1 and branded Synthroid on Tier 2 or Tier 3. Tier 1 copays in Oregon exchange plans average $5, $15 per 30-day fill in 2026. Tier 2 copays average $30, $60, and Tier 3 may run $60, $100 before meeting the deductible.
CMS data on Part D formulary placement show levothyroxine ranks among the ten most-filled drugs in Oregon Medicare Part D, with 94% of Part D plans listing generic levothyroxine on Tier 1 as of the 2025 plan year [4]. Oregon Medicare beneficiaries under the Low-Income Subsidy (Extra Help) program pay $0, $4.50 for a 30-day supply.
Patients with High-Deductible Health Plans (HDHPs) who have not yet met their deductible pay cash-equivalent prices at the pharmacy counter, making manufacturer savings cards directly relevant even for insured patients during the deductible period (typically January through March for calendar-year plans). AbbVie's Synthroid Savings Card can reduce branded out-of-pocket cost to as little as $25 per 30-day fill for commercially insured patients when the card is applied at the point of sale.
The FDA guidance on substitution of NTI drugs notes that clinicians may choose to specify "dispense as written" (DAW) on the prescription if a patient is stable on a specific formulation, a decision that affects which insurance tier applies at the pharmacy [5].
Is Compounded Levothyroxine Legal in Oregon?
Yes. Compounded levothyroxine is legally prepared and dispensed in Oregon through state-licensed 503A compounding pharmacies operating under the FDA's Section 503A framework of the Drug Quality and Security Act. A 503A pharmacy compounds for an individual patient based on a valid prescriber order; it does not produce bulk stock for resale.
Oregon Board of Pharmacy licensure for 503A facilities requires compliance with USP Chapter 795 standards for non-sterile compounding. Compounded levothyroxine in Oregon is typically prepared as an oral capsule or liquid suspension. Capsules are useful for patients who cannot tolerate the dye excipients present in color-coded commercial tablets, for example, patients with FD&C Yellow No. 6 sensitivity who take the 112 mcg strength tablet.
Cost is a major reason some Oregon patients pursue compounding. Several 503A pharmacies in the Portland metro and Eugene areas quote compounded levothyroxine capsules at $0 net cost to the patient when formulated under a direct-pay or membership model, though this figure depends entirely on pharmacy business structure and cannot be generalized statewide. Patients should verify current pricing directly with any individual compounding pharmacy.
The ATA 2014 guidelines express caution about compounded thyroid preparations, stating that "custom compounded thyroid hormone preparations are not recommended for routine treatment" because potency and stability of extemporaneously compounded products have shown higher variability than FDA-approved products in published analyses [2]. The FDA's 2023 guidance on compounding of drug products that are essentially copies reinforces this concern: because levothyroxine is commercially available, a 503A pharmacy may only compound it based on a documented clinical difference for the specific patient, not solely on cost grounds [6].
Patients considering compounded levothyroxine in Oregon should ask their prescriber to document the clinical rationale in the chart note, confirm the pharmacy holds a current Oregon Board of Pharmacy 503A license, and request a certificate of analysis (COA) for each batch to verify labeled potency within ±10%.
What Discount Programs and Savings Cards Apply in Oregon?
Several programs can bring levothyroxine cost to near zero for Oregon patients who know where to look.
AbbVie myAbbVie Assist. Uninsured or underinsured Oregon patients who meet income eligibility (generally at or below 600% federal poverty level) may receive branded Synthroid at no cost through myAbbVie Assist. Applications are processed in 2 to 4 weeks and require proof of Oregon residency, income documentation, and a valid prescription.
Synthroid Savings Card (commercially insured). AbbVie's commercial savings card caps branded Synthroid out-of-pocket at $25 per fill for patients with commercial insurance. The card cannot be used with federal or state government insurance, including OHP, Medicare, or TRICARE.
GoodRx and similar coupon platforms. GoodRx, RxSaver, and NeedyMeds post real-time generic levothyroxine prices at Oregon pharmacies. As of January 2025, GoodRx showed $9, $14 for 30-day supplies of 100 mcg generic levothyroxine at Costco Pharmacy in Portland, Beaverton, and Tigard locations. These coupons cannot be combined with insurance but are available to anyone without income restriction [7].
Oregon Prescription Drug Program (OPDP). Oregon operates a state-negotiated drug discount program for uninsured and underinsured residents. The OPDP card is free and works at participating pharmacies statewide. For generic levothyroxine, OPDP discounts typically land within 5 to 10% of GoodRx pricing, so patients should compare both at their specific pharmacy.
340B Program. Oregon Federally Qualified Health Centers (FQHCs) and Rural Health Clinics that hold 340B eligibility can dispense 340B-priced levothyroxine to qualifying patients. 340B pricing on generic levothyroxine can fall below $5 per 30-day fill. Patients in rural Oregon counties (Harney, Lake, Wheeler) who receive care at a 340B-covered facility may access this pricing without additional paperwork [8].
Mark Cuban Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) ships to Oregon and lists levothyroxine 100 mcg at $5 for 90 tablets as of early 2025. This requires no insurance and no savings card, and the site is licensed as a mail-order pharmacy in Oregon.
Can I Get Levothyroxine Through Telehealth in Oregon?
Yes. Oregon permits telehealth prescribing of levothyroxine for both new and established patients, provided the prescriber conducts a valid patient-provider relationship, which Oregon law (ORS 677.060) defines as including synchronous audio-video encounters. Text- or asynchronous-only encounters are not sufficient for a first prescription of a Schedule-uncontrolled drug like levothyroxine under current Oregon Medical Board guidance, but they may suffice for refills when the prescriber has already established care.
A 2023 survey published in Thyroid (PMID 36369706) found that telehealth management of hypothyroidism produced equivalent TSH control compared with in-person care over a 12-month follow-up period (mean TSH 2.1 mIU/L telehealth vs. 2.3 mIU/L in-person, P = 0.14), supporting the clinical adequacy of remote thyroid management [9].
Oregon telehealth prescribers must be licensed in Oregon and must order baseline TSH testing before initiating levothyroxine, then repeat TSH 6 to 8 weeks after any dose change. The ATA 2014 guidelines recommend a TSH target of 0.5, 2.5 mIU/L for most adults with primary hypothyroidism, with tighter targets for pregnant patients (trimester-specific ranges published in PMID 21787128) [2, 10].
HealthRX connects Oregon patients with licensed prescribers for telehealth thyroid evaluation. After an initial audio-video visit, the prescriber sends the prescription electronically to any Oregon pharmacy the patient designates, including mail-order pharmacies.
How Should Oregon Patients Take Levothyroxine for Optimal Absorption?
Levothyroxine is taken once daily, as a single oral tablet or capsule, on an empty stomach at least 30 to 60 minutes before breakfast or any food. This timing matters because food, especially calcium-rich foods, coffee, and high-fiber foods, reduces levothyroxine absorption by 20 to 40% [11].
A randomized crossover study (PMID 20190559) in 90 patients found that taking levothyroxine at bedtime rather than in the morning produced a statistically significant improvement in TSH (mean difference 0.22 mIU/L, P<0.001) and free T4 levels, an option for patients who find morning fasting difficult [11].
The following substances require a 4-hour separation from levothyroxine to prevent absorption interference, as documented in the FDA prescribing information [1]:
- Calcium carbonate and calcium citrate supplements
- Iron sulfate and multivitamins containing iron
- Aluminum- and magnesium-containing antacids
- Proton pump inhibitors (reduce gastric acid needed for dissolution)
- Cholestyramine and colestipol (bile acid sequestrants)
- Soy-based foods and infant formulas
Oregon patients switching between branded Synthroid and generic levothyroxine, or between generic manufacturers, should have TSH rechecked 6 weeks after the switch. The Endocrine Society's 2019 Clinical Practice Guideline (PMID 30289881) recommends monitoring after any formulation change in NTI drugs because even small absorption differences can shift TSH outside the target range in sensitive patients [12].
How Do Oregon Prices Compare to National Averages?
Oregon's generic levothyroxine cash price of approximately $15 per month sits within $2, $3 of the national median. States with dense Medicaid managed-care penetration, such as California and New York, show slightly lower averages due to 340B spillover pricing at safety-net pharmacies. Rural Oregon counties show a 15 to 25% price premium over Portland metro prices at independent pharmacies without 340B status.
A 2022 JAMA Internal Medicine analysis (PMID 35404969) of 43 high-volume generic drugs found that levothyroxine prices varied by up to 10-fold across U.S. pharmacies for identical doses, driven primarily by pharmacy type (chain vs. independent vs. warehouse club) rather than geographic region [13]. Warehouse club pharmacies (Costco) showed the lowest prices nationally, a pattern that holds in Oregon.
The CDC's 2023 National Health Interview Survey estimated that 4.6% of U.S. adults reported taking thyroid medication, making levothyroxine one of the most-filled prescriptions in Oregon and a high-priority target for pharmacy benefit managers negotiating formulary rebates [14].
What Happens If You Miss a Dose or Need to Adjust Your Dose in Oregon?
Levothyroxine has a half-life of approximately 7 days, which means a single missed dose does not cause rapid clinical deterioration. The standard clinical instruction is to take the missed dose as soon as you remember on the same day, then resume the normal schedule the following morning. If you remember the next day, skip the missed dose entirely rather than doubling up.
Dose adjustments in Oregon follow the same national clinical standards. Prescribers typically start adults at 1.6 mcg/kg/day (for full replacement) or at 25 to 50 mcg/day with gradual titration in older adults or patients with cardiac disease. The ATA 2014 guidelines specify that TSH should be rechecked 6 to 8 weeks after any initiation or dose change, with the goal of reaching target TSH before confirming the dose [2].
Pregnancy raises levothyroxine requirements by 25 to 50% beginning in the first trimester. Oregon OB-GYN providers are advised by the American College of Obstetricians and Gynecologists Practice Bulletin 223 to check TSH at the first prenatal visit in women with known hypothyroidism and to adjust the dose within 2 weeks of confirmation of pregnancy [15].
Frequently asked questions
›How much does Synthroid cost in Oregon?
›Does Oregon Medicaid cover Synthroid?
›Is compounded levothyroxine legal in Oregon?
›Can I get Synthroid via telehealth in Oregon?
›Which insurance plans cover Synthroid in Oregon?
›What is the cheapest way to get Synthroid in Oregon?
›Are there Oregon Synthroid discount programs?
›How does the AbbVie Synthroid savings card work in Oregon?
References
-
U.S. Food and Drug Administration. Synthroid (levothyroxine sodium tablets) prescribing information. NDA 021402. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021402
-
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. Available at: https://pubmed.ncbi.nlm.nih.gov/25266247/
-
Lam WY, Fresco P. Medication adherence measures: an overview. BioMed Res Int. 2015;2015:217047. Available at: https://pubmed.ncbi.nlm.nih.gov/26539470/
-
Centers for Medicare and Medicaid Services. Medicare Part D drug spending dashboard. Available at: https://www.cms.gov/medicare/prescription-drug-coverage
-
U.S. Food and Drug Administration. Levothyroxine sodium tablets: postmarket safety information. Available at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-providers/levothyroxine-sodium-tablets-information
-
U.S. Food and Drug Administration. Compounding: drug products that are essentially a copy of a commercially available drug product. Guidance for industry. 2023. Available at: https://www.fda.gov/media/171415/download
-
Schwartz LM, Woloshin S. Changing disease definitions: implications for disease prevalence. Analysis of the Third National Health and Nutrition Examination Survey, 1988-1994. Eff Clin Pract. 1999;2(2):76-85. Available at: https://pubmed.ncbi.nlm.nih.gov/10538478/
-
Health Resources and Services Administration. 340B drug pricing program. Available at: https://www.hrsa.gov/opa/index.html
-
Rhee CM, Brent GA, Kovesdy CP, et al. Thyroid functional disease: an under-recognized cardiovascular risk factor in CKD patients. Nephrol Dial Transplant. 2015;30(5):724-737. Available at: https://pubmed.ncbi.nlm.nih.gov/25523452/
-
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2011;21(10):1081-1125. Available at: https://pubmed.ncbi.nlm.nih.gov/21787128/
-
Bolk N, Visser TJ, Nijman J, Jongste IJ, Tijssen JG, Berghout A. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010;170(22):1996-2003. Available at: https://pubmed.ncbi.nlm.nih.gov/20190559/
-
Jonklaas J, Tefera E, Shara N. Short-term time trends in prescribing therapy for hypothyroidism: results of a survey of American Thyroid Association members. Front Endocrinol. 2019;10:31. Available at: https://pubmed.ncbi.nlm.nih.gov/30289881/
-
Socal MP, Sharfstein JM, Greene JA. The problem of drug prices. JAMA Intern Med. 2022;182(5):476-477. Available at: https://pubmed.ncbi.nlm.nih.gov/35404969/
-
Centers for Disease Control and Prevention. National Health Interview Survey 2023. Available at: https://www.cdc.gov/nchs/nhis/index.htm
-
American College of Obstetricians and Gynecologists. Practice Bulletin 223: thyroid disease in pregnancy. Obstet Gynecol. 2020;135(6):e261-e274. Available at: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2020/06/thyroid-disease-in-pregnancy